The United States biologics market size was valued at USD 190.3 Billion in 2024 and is projected to reach USD 371.0 Billion by 2033, growing at a CAGR of 7.4% from 2025-2033. This growth is driven by the adoption of advanced bioprocessing technologies, the expansion of biosimilars for affordability, and increased AI integration in drug development, clinical trials, and manufacturing.